Diagnostic Potential of Serum VEGF-D for Lymphangioleiomyomatosis

類似資料

• Serum vascular endothelial growth factor-D as a diagnostic and therapeutic biomarker for lymphangioleiomyomatosis
  著者:: Hirose, Masaki, 等
  出版事項: (2019)
• Lymphangioleiomyomatosis
  著者:: McCormack, Francis X.
  出版事項: (2006)
• Serum VEGF-D concentration as a biomarker of lymphangioleiomyomatosis severity and treatment response: a prospective analysis of the Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus (MILES) trial
  著者:: Young, Lisa R, 等
  出版事項: (2013)
• Author's Reply to “Reader's Response to ‘Lymphangioleiomyomatosis’”
  著者:: McCormack, Francis X.
  出版事項: (2006)
• Serum Vascular Endothelial Growth Factor-D Prospectively Distinguishes Lymphangioleiomyomatosis From Other Diseases
  著者:: Young, Lisa R., 等
  出版事項: (2010)